CARGO Therapeutics Common Stock Statistics
Share Statistics
CARGO Therapeutics Common Stock has 46.03M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 46.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | 2.38K |
| FTD / Avg. Volume | 0.88% |
Short Selling Information
The latest short interest is 5.57M, so 12.14% of the outstanding shares have been sold short.
| Short Interest | 5.57M |
| Short % of Shares Out | 12.14% |
| Short % of Float | 17.44% |
| Short Ratio (days to cover) | 31.64 |
Valuation Ratios
The PE ratio is -9.72 and the forward PE ratio is -4.54.
| PE Ratio | -9.72 |
| Forward PE | -4.54 |
| PS Ratio | 0 |
| Forward PS | 760.8 |
| PB Ratio | 2.35 |
| P/FCF Ratio | -10.58 |
| PEG Ratio | n/a |
Enterprise Valuation
CARGO Therapeutics Inc. Common Stock has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 19.35, with a Debt / Equity ratio of 0.01.
| Current Ratio | 19.35 |
| Quick Ratio | 19.35 |
| Debt / Equity | 0.01 |
| Total Debt / Capitalization | 0.56 |
| Cash Flow / Debt | -35.63 |
| Interest Coverage | -60.29 |
Financial Efficiency
Return on equity (ROE) is -0.24% and return on capital (ROIC) is -22.29%.
| Return on Equity (ROE) | -0.24% |
| Return on Assets (ROA) | -0.22% |
| Return on Capital (ROIC) | -22.29% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -577.34K |
| Employee Count | 170 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -24.45% in the last 52 weeks. The beta is 0, so CARGO Therapeutics Common Stock's price volatility has been lower than the market average.
| Beta | 0 |
| 52-Week Price Change | -24.45% |
| 50-Day Moving Average | 19.01 |
| 200-Day Moving Average | 19.45 |
| Relative Strength Index (RSI) | 30.82 |
| Average Volume (20 Days) | 270.60K |
Income Statement
In the last 12 months, CARGO Therapeutics Common Stock had revenue of $0 and earned -$98.15M in profits. Earnings per share was $-2.38.
| Revenue | 0 |
| Gross Profit | -3.69M |
| Operating Income | -96.71M |
| Net Income | -98.15M |
| EBITDA | -93.02M |
| EBIT | - |
| Earnings Per Share (EPS) | -2.38 |
Balance Sheet
The company has $405.73M in cash and $28.54M in debt, giving a net cash position of $377.19M.
| Cash & Cash Equivalents | 405.73M |
| Total Debt | 28.54M |
| Net Cash | 377.19M |
| Retained Earnings | -145.15M |
| Total Assets | 450.96M |
| Working Capital | 388.38M |
Cash Flow
In the last 12 months, operating cash flow was -$81.16M and capital expenditures -$8.99M, giving a free cash flow of -$90.16M.
| Operating Cash Flow | -81.16M |
| Capital Expenditures | -8.99M |
| Free Cash Flow | -90.16M |
| FCF Per Share | -2.19 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
CRGX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -17.35% |
| FCF Yield | -14.28% |
Analyst Forecast
The average price target for CRGX is $32.5, which is 136.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $32.5 |
| Price Target Difference | 136.9% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Scores
| Altman Z-Score | 7.76 |
| Piotroski F-Score | 2 |